Novavax Inc (NVAX) — Capital Reinvestment Ratio
Latest as of September 2025:
0.02x
Novavax Inc (NVAX) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow ($107.80 Million) in capital expenditures ($2.02 Million). See Novavax Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$107.80 Million
USD
Capital Expenditures
$2.02 Million
USD
Data as of
Sep 2025
Most recent filing
Novavax Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Novavax Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Novavax Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Novavax Inc from 2021 to 2021. For live market cap and broader valuation context, see market value of Novavax Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.18x | $322.95 Million | $57.49 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow